2,179 results on '"D'Amato, Maria"'
Search Results
2. Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
3. Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
4. Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
5. Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
6. Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score
7. Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry
8. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
9. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
10. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
11. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study
12. Signs and symptoms of COVID‐19 in patients with multiple sclerosis
13. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course
14. Improving paediatric movement disorders care: Insights on rating scales utilization and clinical practice
15. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
16. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
17. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
18. Impact of biologics on lung hyperinflation in patients with severe asthma
19. Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
20. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis
21. Climate Change, Air Pollution and Respiratory Health
22. Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis
23. The Comorbid Patient in the Spotlight: Efficacy of Benralizumab on Chronic Rhinosinusitis with Nasal Polyp Outcomes in Presence of Severe Asthma
24. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
25. On the ethics of informed consent in genetic data collected before 1997
26. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
27. Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis
28. Chemical characterization of four ancient white wine grapes (Vitis vinifera L.) from the Amalfi coast
29. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
30. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
31. Pollen respiratory allergy: Is it really seasonal?
32. The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study
33. Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
34. Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
35. Genetic heritage of the Baphuthi highlights an over-ethnicized notion of “Bushman” in the Maloti-Drakensberg, southern Africa
36. Oleanolic acid: A promising antidiabetic metabolite detected in Aglianico grape pomace
37. Family planning considerations in people with multiple sclerosis
38. Sex effects across the lifespan in women with multiple sclerosis
39. Multiple sclerosis progression: time for a new mechanism-driven framework
40. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register
41. Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple Sclerosis
42. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
43. Effects of Cognitive Rehabilitation on Brain Grey Matter Volume and Go-noGo Activity in Progressive Multiple Sclerosis: Results from the CogEx Study (S42.010)
44. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
45. The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience
46. A comprehensive GlobalFiler™ autosomal STR reference dataset for Southern Africa
47. A machine learning approach to characterize patients with asthma exacerbation attending an acute care setting
48. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
49. Climate change, air pollution, pollen allergy and extreme atmospheric events
50. Job satisfaction among physicians and nurses involved in the management of multiple sclerosis: the role of happiness and meaning at work
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.